Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now KSE - Delayed Quote • KRW Hanmi Pharm. Co., Ltd. (128940.KS) Follow Add holdings 265,500.00 -3,500.00 (-1.30%) At close: May 2 at 3:30:14 PM GMT+9 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 128940.KS 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 128940.KS View More All News Press Releases SEC Filings Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss Related Tickers 237690.KQ ST Pharm Co.,Ltd. 78,900.00 -0.13% 389470.KQ Inventage Lab, Inc. 46,900.00 +29.92% 009420.KS Hanall Biopharma Co., Ltd. 28,200.00 +1.62% AZFL Amazonas Florestal, Ltd 0.0001 0.00% BCRX BioCryst Pharmaceuticals, Inc. 8.93 +2.53% AKBA Akebia Therapeutics, Inc. 2.4500 +2.51%